clenbuterol and dinoprostone

clenbuterol has been researched along with dinoprostone in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Archer, J; Haines, DM; Kästner, SB; Townsend, HG	1
Doornbos, RP; Rodenburg, RJ; van der Greef, J; Verhoeckx, KC; Witkamp, RF	1

Trials

1 trial(s) available for clenbuterol and dinoprostone

Article	Year
Investigations on the ability of clenbuterol hydrochloride to reduce clinical signs and inflammation associated with equine influenza A infection. Equine veterinary journal, 1999, Volume: 31, Issue:2 Topics: Adrenergic beta-Agonists; Animals; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Clenbuterol; Cough; Dinoprost; Dinoprostone; Double-Blind Method; Female; Fever; Horse Diseases; Horses; Influenza A virus; Leukocyte Count; Male; Orthomyxoviridae Infections	1999

Article

Year

Investigations on the ability of clenbuterol hydrochloride to reduce clinical signs and inflammation associated with equine influenza A infection.

Equine veterinary journal, 1999, Volume: 31, Issue:2

Topics: Adrenergic beta-Agonists; Animals; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Clenbuterol; Cough; Dinoprost; Dinoprostone; Double-Blind Method; Female; Fever; Horse Diseases; Horses; Influenza A virus; Leukocyte Count; Male; Orthomyxoviridae Infections

1999

Other Studies

1 other study(ies) available for clenbuterol and dinoprostone

Article	Year
Beta-adrenergic receptor agonists induce the release of granulocyte chemotactic protein-2, oncostatin M, and vascular endothelial growth factor from macrophages. International immunopharmacology, 2006, Volume: 6, Issue:1 Topics: Adrenergic beta-Agonists; Bucladesine; Chemokine CXCL6; Chemokines, CXC; Clenbuterol; Colforsin; Cyclic AMP; Cytokines; Dinoprostone; Humans; Lipopolysaccharides; Macrophage Activation; Macrophages; Oncostatin M; Trimethylsilyl Compounds; U937 Cells; Up-Regulation; Vascular Endothelial Growth Factor A	2006

Article

Year

Beta-adrenergic receptor agonists induce the release of granulocyte chemotactic protein-2, oncostatin M, and vascular endothelial growth factor from macrophages.

International immunopharmacology, 2006, Volume: 6, Issue:1

Topics: Adrenergic beta-Agonists; Bucladesine; Chemokine CXCL6; Chemokines, CXC; Clenbuterol; Colforsin; Cyclic AMP; Cytokines; Dinoprostone; Humans; Lipopolysaccharides; Macrophage Activation; Macrophages; Oncostatin M; Trimethylsilyl Compounds; U937 Cells; Up-Regulation; Vascular Endothelial Growth Factor A

2006